These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23431225)

  • 1. Reproducibility of dynamic contrast-enhanced MR imaging: why we should care.
    Goh V; Schaeffter T; Leach M
    Radiology; 2013 Mar; 266(3):698-700. PubMed ID: 23431225
    [No Abstract]   [Full Text] [Related]  

  • 2. Reproducibility of dynamic contrast-enhanced MR imaging.
    Thomassin-Naggara I; Cuenod CA; Balvay D
    Radiology; 2013 Nov; 269(2):620-1. PubMed ID: 24155287
    [No Abstract]   [Full Text] [Related]  

  • 3. Response.
    Heye TJ; Boll DT
    Radiology; 2013 Nov; 269(2):621. PubMed ID: 24312936
    [No Abstract]   [Full Text] [Related]  

  • 4. Reproducibility of dynamic contrast-enhanced MR imaging. Part II. Comparison of intra- and interobserver variability with manual region of interest placement versus semiautomatic lesion segmentation and histogram analysis.
    Heye T; Merkle EM; Reiner CS; Davenport MS; Horvath JJ; Feuerlein S; Breault SR; Gall P; Bashir MR; Dale BM; Kiraly AP; Boll DT
    Radiology; 2013 Mar; 266(3):812-21. PubMed ID: 23220891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions.
    Heye T; Davenport MS; Horvath JJ; Feuerlein S; Breault SR; Bashir MR; Merkle EM; Boll DT
    Radiology; 2013 Mar; 266(3):801-11. PubMed ID: 23220897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of precontrast T10 relaxation times on dynamic contrast-enhanced MRI pharmacokinetic parameters: T10 mapping versus a fixed T10 reference value.
    Heye T; Boll DT; Reiner CS; Bashir MR; Dale BM; Merkle EM
    J Magn Reson Imaging; 2014 May; 39(5):1136-45. PubMed ID: 25006630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model.
    Davenport MS; Heye T; Dale BM; Horvath JJ; Breault SR; Feuerlein S; Bashir MR; Boll DT; Merkle EM
    J Magn Reson Imaging; 2013 Aug; 38(2):329-35. PubMed ID: 23239041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the vascularity of uterine leiomyomas using double-echo dynamic perfusion-weighted MRI with the first-pass pharmacokinetic model: correlation with histopathology.
    Kosaka N; Uematsu H; Kimura H; Ishimori Y; Kurokawa T; Matsuda T; Itoh H
    Invest Radiol; 2007 Sep; 42(9):629-35. PubMed ID: 17700278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unenhanced MR angiography of uterine and ovarian arteries after uterine artery embolization: differences between patients with incomplete and complete fibroid infarction.
    Mori K; Saida T; Shibuya Y; Takahashi N; Shiigai M; Osada K; Tanaka N; Minami M
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):515-22. PubMed ID: 21584841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical Signaling and Extracellular Matrix in Uterine Fibroids.
    Rafique S; Segars JH; Leppert PC
    Semin Reprod Med; 2017 Nov; 35(6):487-493. PubMed ID: 29100236
    [No Abstract]   [Full Text] [Related]  

  • 11. [Integrins and prolidase activity in uterine leiomyoma during tumor growth].
    Wolańska M; Sobolewski K; Drozdzewicz M
    Ginekol Pol; 2001 Mar; 72(3):121-6. PubMed ID: 11398579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine myxoid leiomyosarcoma within a leiomyoma.
    Mittal K; Popiolek D; Demopoulos RI
    Hum Pathol; 2000 Mar; 31(3):398-400. PubMed ID: 10746687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced MR angiography of uterine arteries for the prediction of ovarian artery embolization in 349 patients.
    Lee MS; Kim MD; Lee M; Won JY; Park SI; Lee DY; Lee KH
    J Vasc Interv Radiol; 2012 Sep; 23(9):1174-9. PubMed ID: 22920980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis and histogenesis of uterine leiomyoma and their correlation with the endocrine functions].
    Fujii S
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Aug; 35(8):1166-74. PubMed ID: 6578276
    [No Abstract]   [Full Text] [Related]  

  • 15. [Basic fibroblast growth factor in leiomyoma].
    Wolańska M; Sobolewski K
    Pol Merkur Lekarski; 2004 Dec; 17(102):590-2. PubMed ID: 15771129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of a case of uterine leiomyoma showing massive lymphoid infiltration and localized vasculitis after LH-RH derivant treatment.
    Ohmori T; Wakamoto R; Lu LM; Okada K; Nose M
    Histopathology; 2002 Sep; 41(3):276-7. PubMed ID: 12207795
    [No Abstract]   [Full Text] [Related]  

  • 17. [Highly cellular leiomyoma of uterus with diffuse plexiform pattern resembling sex-cord tumor: report of a case].
    Zhu YL; Yang YP; Dong CG; Zhang JM
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):415-6. PubMed ID: 22932415
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship between the amount of stroma in uterine myomas and the patients' age].
    Korchagin GM; Pashkova VS
    Akush Ginekol (Mosk); 1974 Oct; (10):61. PubMed ID: 4440837
    [No Abstract]   [Full Text] [Related]  

  • 19. An engaging example of translational medicine: the Wnt/β-catenin cellular pathway and pharmacological research in fibroid treatment.
    Serna J
    Fertil Steril; 2014 May; 101(5):1254. PubMed ID: 24786745
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of progesterone receptor form A and B mRNAs in uterine leiomyoma.
    Fujimoto J; Hirose R; Ichigo S; Sakaguchi H; Li Y; Tamaya T
    Tumour Biol; 1998; 19(2):126-31. PubMed ID: 9486564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.